...received rights to develop, manufacture and market PG490-88Na worldwide, excluding Taiwan, China and Hong Kong. Pharmagenesis...
...the compound. Pharmagenesis will receive an upfront fee and is eligible for milestones and royalties. Pharmagenesis...
...PhytoHealth joint venture and in China and Hong Kong through its Tianjin Hualong joint venture. Pharmagenesis Inc....

...of intravenous PG490-88Na in 30 patients with advanced solid tumors who have failed standard therapy. Pharmagenesis Inc....

...The companies will research the use of triptolide derivatives from Pharmagenesis to treat autoimmune conditions. Fujisawa...
...conditions. Fujisawa has an option to acquire the exclusive worldwide development and marketing rights to Pharmagenesis'...
...the principle active component of the traditional Chinese medical plant called Tripterygium wilfordii Hook F. Pharmagenesis Inc....

...Pharmagenesis has exclusive distribution rights in China and Taiwan. Advanced Magnetics Inc. (AVM), Cambridge, Mass. Pharmagenesis Inc....

...Cancer Hired: Robert Tidwell as VP of business development, formerly VP and general manager at Pharmagenesis Inc. WIR...

...SPP Ltd. (Suzhou, China), a joint venture to manufacture and commercialize Pharmagenesis' products in China. Pharmagenesis...
...and regulatory submissions. President Pharmaceutical is the largest shareholder, while Pharmagenesis is the second largest. Pharmagenesis...
...Chinese Phase I trials of PG2, which is derived from traditional Chinese medicine (see B13). Pharmagenesis Inc....

...in the U.S., Japan, South Korea, Europe and Brazil. Advanced Magnetics Inc. (AVM) Cambridge, Mass. Pharmagenesis Inc....

...antifungal agents derived from microorganisms associated with plants known to be resistant to fungal infections. Pharmagenesis's...
...that demonstrate antifungal activity. Lilly is responsible for preclinical and clinical development of lead compounds. Pharmagenesis...
...product rights to applications for cardiovascular diseases, CNS diseases, cancer, infectious diseases, and hormonal disorders. Pharmagenesis Inc....

...Corp. (AZA) Pharmagenesis Inc. (Palo Alto) will commercialize Testoderm in China, Hong Kong, Macau and Taiwan. Pharmagenesis...
...OROS pseudoephedrine, in those four countries as well as Indonesia, Malaysia, Sing-apore, Thailand and Vietnam. Pharmagenesis...